Ralph Wendt

Head of nephrology

St George's Hospital

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ralph Wendt is the Head of Nephrology at Klinikum Sankt Georg gGmbH in Germany. His research primarily focuses on kidney function, chronic kidney disease, and the implications of urinary biomarkers, as evidenced by his recent articles. He has contributed significantly to understanding nephrotic syndromes, monitoring drug-related adverse events, and evaluating outcomes in COVID-19 patients with renal complications.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (5)

Christoph Luebbert

Head of Division

University Hospital Leipzig

GERMANY

View details

Mirosław Banasik

Wroclaw Medical University

POLAND

View details

Anja Saalbach

Leipzig University

GERMANY

View details

Magdalena Dzitkowska-Zabielska

Medical University of Gdansk

POLAND

View details

Lorenzo Catanese

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ralph Wendt

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Monitoring Plasma Concentrations of Intravenously Administered Fosfomycin to Prevent Drug-Related Adverse Events: A Retrospective Observational Study

Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers

Non-Invasive Biomarkers for Diagnosis, Risk Prediction, and Therapy Guidance of Glomerular Kidney Diseases: A Comprehensive Review

Mortality Risk and Urinary Proteome Changes in Acute COVID-19 Survivors in the Multinational CRIT-COV-U Study

Serum uromodulin associates with kidney function and outcome in a cohort of hospitalised COVID-19 patients

An Updated Comprehensive Review on Diseases Associated with Nephrotic Syndromes

Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review

Antifibrotic Soluble Thy-1 Correlates with Renal Dysfunction in Chronic Kidney Disease

Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study

Alternate‐day dosing of caplacizumab for immune‐mediated thrombotic thrombocytopenic purpura

Collaborators (5)

Christoph Luebbert

Mirosław Banasik

Anja Saalbach

Magdalena Dzitkowska-Zabielska

Lorenzo Catanese

Make your next move.